Connection
Andrew Morris to Glucocorticoids
This is a "connection" page, showing publications Andrew Morris has written about Glucocorticoids.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.372 |
|
|
|
-
Martinez GJ, Kipp ZA, Lee WH, Bates EA, Morris AJ, Marino JS, Hinds TD. Glucocorticoid resistance remodels liver lipids and prompts lipogenesis, eicosanoid, and inflammatory pathways. Prostaglandins Other Lipid Mediat. 2024 Aug; 173:106840.
Score: 0.187
-
Prabakaran AD, McFarland K, Miz K, Durumutla HB, Piczer K, El Abdellaoui Soussi F, Latimer H, Werbrich C, Chung HJ, Blair NS, Millay DP, Morris AJ, Prideaux B, Finck BN, Quattrocelli M. Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1a/Lipin1 axis in an aging-related sarcopenia model. J Clin Invest. 2024 May 03; 134(11).
Score: 0.186
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|